Subscribe

Level of cost sharing faced by patients with cancer

VBCC - Media Library - Pricing
Michael Kolodziej, MD
National Medical Director
Oncology Solutions
Aetna
Hartford, CT

The system by which healthcare is paid for in general clearly impacts how healthcare is obviously paid for in cancer. The vast majority of Americans get health insurance through employer‑sponsored health insurance plans, and then Medicare is another big payer.

Over time, and especially now, there’s a lot of discussion about passing some of these price increases, cost increases to the patient. I think that’s really a challenge. It’s a challenge for patients. It’s a challenge for the plan.

We do not want patients to make bad decisions because of cost. We do not want to promote nonadherence with oral drugs, for example, because of cost. Yet, we would like patients to feel that they have some skin in the game, that their decisions are not cost‑insensitive. There’s a very fine line here. Because of the cost of cancer therapy, I think we have to be really careful about how far this goes.

We should also never forget that the maximum out‑of‑pocket cost, which has been defined by the ACA, may not seem like a lot of money if you’re a doctor or a lawyer, but for the average American family, it’s a heck of a lot of money. I think we better not forget that. How we ask patients to participate in a value‑driven fashion, that’s going to be a real trick.

Related Items
The Role of Oncologists in Defining the Value of Cancer Therapy
Michael Kolodziej, MD
VBCC - August 2015, Vol 6, No 7 published on August 18, 2015 in VBCC Perspectives
Affordability + Clinical Effectiveness = The Value Equation
C. Daniel Mullins, PhD
VBCC - Media Library published on March 25, 2015 in Pricing
Providing Patients with Cost Information
C. Daniel Mullins, PhD
VBCC - Media Library published on March 25, 2015 in Pricing
New Conversations About Costs of Cancer Care
C. Daniel Mullins, PhD
VBCC - Media Library published on March 25, 2015 in Pricing
Keeping Cost Out of the Drug Approval Debate
Andrew Stainthorpe, PhD
VBCC - Media Library published on March 25, 2015 in Pricing
Value-Based Concerns of European Oncologists
Andrew Stainthorpe, PhD
VBCC - Media Library published on March 25, 2015 in Pricing
Approaches to Alleviating Costs for Patients and Payers
Andrew Stainthorpe, PhD
VBCC - Media Library published on March 25, 2015 in Pricing
Value-Based Concerns - What Matters?
Linda Bosserman, MD, FACP
VBCC - Media Library published on March 25, 2015 in Pricing
Cost Is Crucial When Evaluating Treatment
Linda Bosserman, MD, FACP
VBCC - Media Library published on March 25, 2015 in Pricing
The Imperative to Discuss Cost of Care with Patients with Cancer
Michael Kolodziej, MD
VBCC - February 2015, Vol 6, No 1 published on February 19, 2015 in VBCC Perspectives
Last modified: September 29, 2015
  • Rheumatology Practice Management
  • Lynx CME
  • American Health & Drug Benefits
  • Value-Based Cancer Care
  • Value-Based Care in Myeloma
  • Value-Based Care in Neurology